Hassan Maishera
On Wednesday, the Injective team announced via X that Korea University’s Blockchain Research Institute is now live as an Injective research collaborator and validator. This move deepens Injective’s APAC expansion and brings a top academic institution directly onto the blockchain built for finance.
Through the partnership, Korea University will participate in the Injective ecosystem as a key validator, contributing to network operations, ecosystem growth, and global expansion.
In parallel, both parties will pursue joint research initiatives focused on real-world asset tokenization and onchain financial structures in Korea. Rather than launching isolated pilots, the research will assess structural feasibility, regulatory compatibility, and institutional requirements from the outset. This includes analyzing disclosure obligations, compliance constraints, operational realities, and market demand within the Korean financial system.
Injective is an open, interoperable layer-one blockchain for building powerful DeFi applications. Injective uniquely provides plug-and-play financial infrastructure primitives, such as a high-performance on-chain decentralized exchange infrastructure, decentralized bridges, oracles, and a composable smart contract layer with CosmWasm. INJ is trading at $5.20, down 3.2% in the last 24 hours.
